| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080063678 Novel 2-Cyano-3(Halo)Alkoxy-Benzenesulfonamide Compounds for Combating Animal Pests |
| 03/13/2008 | CA2662091A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 03/12/2008 | EP1896401A2 Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis |
| 03/11/2008 | US7342013 Benzamides and related inhibitors of factor Xa |
| 03/11/2008 | CA2421880C Resorcinol derivatives |
| 03/11/2008 | CA2274954C Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient |
| 03/11/2008 | CA2259216C Methyl 4-iodo-2-[n-(n-alkylaminocarbonyl)aminosulfonyl]benzoate and derivatives thereof, and a process for their preparation |
| 03/11/2008 | CA2223535C 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 03/06/2008 | WO2008027604A2 Production processes and systems, compositions, surfactants monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams and foam stabilizers |
| 03/06/2008 | WO2008026563A1 Hydrazine amide derivative |
| 03/06/2008 | WO2007010356A8 Process for the preparation of sulfonamide derivatives |
| 03/06/2008 | US20080058538 Process for producing fluoroalkanesulfonamide derivatives |
| 03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 03/06/2008 | US20080058290 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders |
| 03/05/2008 | EP1893597A2 Ampa receptor potentiators |
| 03/05/2008 | EP1893565A1 Process and compound |
| 03/05/2008 | EP1709089B1 Water-and oil-repellent fluoroacrylates |
| 03/05/2008 | CN101137650A 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 03/05/2008 | CN100372831C Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| 03/04/2008 | US7339078 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 03/04/2008 | US7338958 Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents |
| 02/28/2008 | WO2008024746A1 4-substituted phenoxyphenylacetic acid derivatives |
| 02/28/2008 | WO2008024303A2 Compounds for treating proliferative disorders |
| 02/28/2008 | WO2007119110A3 Process for the preparation of tamsulosin and related compounds |
| 02/28/2008 | US20080051416 Novel Compounds |
| 02/28/2008 | US20080051374 ophthalmically acceptable for reducing intraocular pressure |
| 02/28/2008 | CA2661164A1 4-substituted phenoxyphenylacetic acid derivatives |
| 02/28/2008 | CA2660524A1 Compounds for treating proliferative disorders |
| 02/27/2008 | EP1891001A1 SULFONAMIDE DERIVATIVES USEFUL AS LIVER CARNITINE PALMITOYL TRANSFERASE (L-CPTl) INHIBITORS |
| 02/27/2008 | EP1890690A2 Mao-b inhibitors useful for treating abesity |
| 02/27/2008 | EP1740530A4 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders |
| 02/27/2008 | EP1695958B1 Method for producing chlorosulfonyl isocyanate |
| 02/27/2008 | EP1418950B1 Solid-phase nucleophilic fluorination |
| 02/27/2008 | CN101133060A Enzyme inhibitors |
| 02/27/2008 | CN101133026A 1- sulfonyl-pi perdine- 3 -carboxyl i c acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus |
| 02/27/2008 | CN101130509A Process for producing sulfonamide- trimethylamine containing fluorine |
| 02/27/2008 | CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | US7335673 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/26/2008 | US7335649 3-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3'-(tetrazol-5-yl)biphenyl for treatment of thrombocytopenia; colony stimulating factors |
| 02/26/2008 | CA2207545C Antiarrhythmic (s)-enantiomers of methanesulfonamides |
| 02/21/2008 | WO2008021804A2 Therapeutic amides and related compounds |
| 02/21/2008 | WO2008005851A3 Compositions containing silanes |
| 02/21/2008 | US20080045499 Preferential Inhibition of Presenilin-1 |
| 02/21/2008 | US20080045483 such as 4-{2-[2-(4-chlorobenzenesulfonylamino)phenyl]ethyl}benzoic acid; hyperglycemic agents |
| 02/21/2008 | DE102006039003A1 Neue Verbindungen New connections |
| 02/21/2008 | CA2660396A1 Therapeutic amides and related compounds |
| 02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
| 02/20/2008 | EP1889838A1 Thrombopoietin mimetics |
| 02/20/2008 | EP1888566A1 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 02/20/2008 | EP1888519A2 Styrylsulfonamides, their manufacture and use as pharmaceutical agents |
| 02/20/2008 | EP1888518A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 02/20/2008 | EP1888517A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 02/20/2008 | EP1697304B1 Peroxisome proliferator activated receptor modulators |
| 02/20/2008 | EP1354871B1 Biphenyl derivatives |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/19/2008 | US7332610 Chemical intermediates for production of sibutramine |
| 02/19/2008 | US7332608 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/19/2008 | CA2324217C Process for the synthesis of hiv protease inhibitors |
| 02/19/2008 | CA2281226C Process for synthesizing .alpha.-substituted ring systems |
| 02/19/2008 | CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | WO2008017925A2 Pharmacodynamic hybrids endowed of hypoglycemic and no-donor activities obtained combining hydroxylated derivatives of glibenclamide and nitrooxy-substituted carboxylic acids |
| 02/14/2008 | WO2008017840A1 Cyclopentanecarboxylic acid derivatives and their use in the treatment of bacterial infectious diseases |
| 02/14/2008 | WO2007147222A9 Novel ionic liquids |
| 02/14/2008 | US20080039662 Isomerizing an alkyl cis-4-(alkylsulfonylamino)cyclohexanecarboxylate to form the trans isomer with a base (alkali metal lower alkoxide, hydride or amide) in an aprotic solvent (toluene); forming the free acid by hydrolysis; sulfonation of alkyl 4-aminocyclohexanecarboxylate with alkylsulfinyl chloride |
| 02/14/2008 | US20080039634 Novel onium salt, electrolyte for nonaqueous cell containing the novel onium salt for nonaqueous cell and method for optimizing negative electrode using electrolyte containing onium salt |
| 02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
| 02/13/2008 | EP1885693A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 |
| 02/13/2008 | EP1885692A2 Process for the preparation of tamsulosin |
| 02/13/2008 | EP1366023B1 Water- and oil-repellency imparting ester oligomers comprising perfluoroalkyl moieties |
| 02/13/2008 | CN101124271A Fluorochemical diesters as repellent polymer melt additives |
| 02/13/2008 | CN100368405C Method for producing substituted phenylsulfonyl carbamides from sulfohalogenides |
| 02/13/2008 | CN100368394C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 02/12/2008 | US7329780 Preparing (R)-5-{2-[2-(2-ethoxyphenoxy)ethylamino]-propyl}-2-methoxybenzenesulfonamide by amidating (R)-2-(4-methoxy-3-aminosulfonyl-phenyl)-1-methylethylamine with a haloacetyl compound, reacting the haloacetamide formed with o-ethoxyphenol or its Na or K salt, and reducing the product. |
| 02/12/2008 | US7329755 especially naphthalene sulfonamides, used for treating asthma |
| 02/07/2008 | WO2008016139A1 Fluorescent oleamide derivative and use thereof |
| 02/07/2008 | WO2008015517A2 Ep2 agonists |
| 02/07/2008 | US20080033208 Process for Manufacturing Optically Pure (R) or (S)-5-(2-Aminopropyl)-2-Methoxybenzene Sulfonamide |
| 02/07/2008 | US20080033207 Preparation of R-5- (2-(2-Ethoxyphenoxyetylamino) -2-Methoxybenzen-Sulphonamide Hydrochloride of High Chemical |
| 02/07/2008 | US20080032983 Ortho-Substituted N'-Benzylidene-(3-Hydroxyphenyl)Acethydrazides |
| 02/07/2008 | US20080032979 Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors |
| 02/07/2008 | US20080031852 inhibitor of HCV NS5B polymerase; to treat infections caused by hepatitis C virus; 3-(1,1-Dioxo-1,4-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-4-hydroxy-1-(3-methyl-butyl)-pyrrolo[1,2-b]pyridazin-2-one |
| 02/06/2008 | CN101117325A Optical rotation N-alkynes propanesulfonamide monomer and method for making same |
| 02/06/2008 | CN100366606C New phenylamidine derivatives process for preparing the same and their use as medicaments |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 01/31/2008 | US20080027246 Process for forming perfluorinated-alkyl sulfonamide substituted norbornene-type monomers |
| 01/31/2008 | US20080027109 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 01/31/2008 | US20080027096 Novel Pharmaceutical Compositions |
| 01/30/2008 | EP1881960A1 Novel specific caspase-10 inhibitors |
| 01/30/2008 | CN101115713A HIV protease inhibitors |
| 01/30/2008 | CN101115488A Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the deritives thereof for the treatment of benign prostate hyperplasia, prostate carcinoma and spinobulbar |
| 01/29/2008 | US7323608 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2008 | US7323596 Antibacterial or antiprotozoal activity: formula (1) formula (2) wherein: Z represents a radical of formula N(OH)CH( .dbd. O) or of formula C( .dbd. O)NH(OH); R1 represents hydrogen, methyl or trifluoromethyl, or, except when Z is a radical of |
| 01/29/2008 | US7323587 Selective estrogen receptor modulators |